Beijing Fiveplus Gene Technology
PrivateLast Round
M&A
Jun 15, 2023
Total Funding Raised
$4.65M
Company Overview
Beijing Fiveplus Gene Technology operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A round in September 2021.
Beijing Fiveplus Gene Technology is a biotechnology company that provides end-to-end contract development and manufacturing organization (CDMO) services for gene therapy medicine research and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Fiveplus Gene Technology Comparables
Compare Beijing Fiveplus Gene Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhejiang Innoforce Pharmaceuticals | 86% | |
| uBriGene Biosciences | 84% | |
| PackGene Biotech | 82% |
For institutional investors. Book with your work email.
Beijing Fiveplus Gene Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jun 15, 2023 | ||||
| Series A | Sep 28, 2021 |
For institutional investors. Book with your work email.
Beijing Fiveplus Gene Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 杭州怀济私募基金管理有限公司 | Series A |
| Hangzhou Aopeng Investment Management Co., Ltd. | Series A |
Beijing Fiveplus Gene Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing Fiveplus Gene Technology's valuation, stock price, and market status.
Is Beijing Fiveplus Gene Technology a public or private company?
Beijing Fiveplus Gene Technology is a private company.
What is the current stock price of Beijing Fiveplus Gene Technology?
Beijing Fiveplus Gene Technology is a private company, so its shares have no public market price. Caplight tracks Beijing Fiveplus Gene Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing Fiveplus Gene Technology worth (valuation)?
Valuation information for Beijing Fiveplus Gene Technology is not publicly available.
Can I buy Beijing Fiveplus Gene Technology stock?
Beijing Fiveplus Gene Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing Fiveplus Gene Technology's last funding round?
Beijing Fiveplus Gene Technology's most recent funding round was M&A on June 15, 2023.
Who are the main investors in Beijing Fiveplus Gene Technology?
Key investors in Beijing Fiveplus Gene Technology include 杭州怀济私募基金管理有限公司, Hangzhou Aopeng Investment Management Co., Ltd..
Will Beijing Fiveplus Gene Technology IPO soon?
No public IPO plans have been announced for Beijing Fiveplus Gene Technology.
How can I track Beijing Fiveplus Gene Technology secondary market activity?
Caplight tracks bids, offers, and trades in Beijing Fiveplus Gene Technology's shares on secondary markets.